New software to detect overdose risk among drug users

A new e-health tool that could help reduce the number of drug-related deaths in Europe will be launched in Brussels today.

The tool, developed by the Orion Project, financed by the European Commission and led by the University of St Andrews, is the first of its kind.  If rolled out successfully, researchers say the tool could help to significantly reduce cases of drug overdose.

Gerald Humphris, Professor of at St Andrews - one of the 4 European research groups involved in the research - said in advance of the launch, "Drug use is one of the major causes of health problems and mortality among young people in Europe and this is a concern for the and regulators alike; this is why we were keen to develop a new tool to detect and raise awareness of the risks of drug overdose.

"The findings from our tests have shown that 45% of patients would consider changing their drug taking behaviour as a result of using the software."

The software is designed to help both patients and medical professionals identify key factors that lead to fatal .

Ms Antigoni Papadopoulou, Member of the European Parliament for Cyprus and convenor of the launch said. "Over the last decade, Europe has experienced about one overdose death every hour.  Europe needs to support more tools and projects like this one that will help policy makers to understand how to prevent and reduce drug demand, particularly among the younger generations."

Representatives from EU Member States are meeting at the to discuss a draft of the EU's drug strategy for 2013-2020. The strategy aims to contribute to a reduction in drug demand use and drug supply within the EU, as well as the health and social risks and harms caused by . The framework of this strategy will serve as basis for two consecutive 4 year EU Drugs Action plans.

More information: orion-euproject.com/

add to favorites email to friend print save as pdf

Related Stories

EU committee rejects clone food plan

May 04, 2010

An EU parliamentary committee on Tuesday rejected a controversial proposal to allow food from cloned animals and their offspring onto the European market.

Recommended for you

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

Aug 21, 2014

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

User comments